EUVIMEDEUVIMED entdecken
Open Access

The third inactivated vaccine booster dramatically enhanced SARS‐CoV‐2 antibody responses and did not influence the profile of prothrombotic antibody

Yunbao Pan iD, Shilin Wang, Guohong Liu, Liping Wang, Liu Yang, Xiaojiao Zeng, Chungen Qian, Jun Lin, Zhenyu Pan, Yirong Li

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Yunbao Pan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Antibodies, Viral, Antibody Formation, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study is to investigate the production of both severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)‐specific antibodies and autoantibodies in serum following the third booster vaccination of the inactivated COVID‐19 vaccine, and to study the effect of B cell subsets with CD27 and CD38 phenotypes in peripheral blood on antibody production. Routine blood indexes, SARS‐CoV‐2 antibodies, platelet factor 4 and seven antiphospholipid antibodies were detected both before and 2 months after vaccination in the medical staff of the Zhongnan Hospital of Wuhan University. Peripheral blood B cell subtypes were detected before vaccination. Following immunization, the positive rate of anti‐N‐S1 immunoglobulin (IgG) had increased from 24.8% to 91.3% and the average antibody concentration had increased by 11 times. The positive rate of neutralizing antibody had increased from 24.8% to 91.3%, the average antibody concentration had increased by 12 times, and the primary increased anti‐S1 IgG subtype was that of IgG1. Peripheral blood CD27 + CD38+ B cells were positively correlated with antibody levels after vaccination and were a predictor of the antibody response. In addition, although some indicators showed slight absolute changes, the blood parameters and antiphospholipid antibodies of most volunteers were normal both before and after COVID‐19 inactivated vaccine inoculation, and there was no statistical difference in abnormal rates either before or after inoculation. Antibodies in vivo were increased after vaccination with the inactivated vaccine, and IgG1 was the main subtype involved in response to the vaccine. Vaccination with the inactivated COVID‐19 vaccine did not appear to affect thrombus‐related autoantibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralAntibody FormationCOVID-19COVID-19 VaccinesSARS-CoV-2HumansAntibodies, AntiphospholipidAntibodies, NeutralizingAutoantibodiesImmunoglobulin GVaccinationVaccines, Inactivated

Stichwörter der Autor:innen

B cell subpopulationCOVID-19SARS-CoV-2antiphospholipid antibodyinactivated vaccine

Substanzen

Antibodies, AntiphospholipidAntibodies, NeutralizingAntibodies, ViralAutoantibodiesCOVID-19 VaccinesImmunoglobulin GVaccines, Inactivated

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.
  • Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, Hubei, China.
  • Wuhan Research Center for Infectious Diseases and Tumors of the Chinese Academy of Medical Sciences, Wuhan, Hubei, China.
  • Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
  • The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering,…
  • Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.

ORCID-Profile: Yunbao Pan

Zitieren

APA

Pan, Y., Wang, S., Liu, G., Wang, L., Yang, L., Zeng, X., Qian, C., Lin, J., Pan, Z., & Li, Y. (2023). The third inactivated vaccine booster dramatically enhanced SARS‐CoV‐2 antibody responses and did not influence the profile of prothrombotic antibody. Journal of Medical Virology. https://doi.org/10.1002/jmv.28356

Vancouver

Pan Y, Wang S, Liu G, Wang L, Yang L, Zeng X, et al. The third inactivated vaccine booster dramatically enhanced SARS‐CoV‐2 antibody responses and did not influence the profile of prothrombotic antibody. Journal of Medical Virology. 2023. doi:10.1002/jmv.28356

BibTeX
@article{Pan2023,
  author = {Pan, Yunbao and Wang, Shilin and Liu, Guohong and Wang, Liping and Yang, Liu and Zeng, Xiaojiao and Qian, Chungen and Lin, Jun and Pan, Zhenyu and Li, Yirong},
  title = {The third inactivated vaccine booster dramatically enhanced SARS‐CoV‐2 antibody responses and did not influence the profile of prothrombotic antibody},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28356}
}
Kostenlos starten →